Baidu
map

梅斯医学

订阅

MedSci主页 / 所有栏目 / 梅斯医学

网状Meta分析怎么写？7.7高分作者手把手教学！

2021-09-26 MedSci原创 MedSci原创

Meta分析meta-analysis
关注

网状meta分析开营了~免费学习领取奖学金

前1000名免费报名（截图微信扫码）

 

Meta分析是凭借它发表速度快，不需要实验操作，结果真实可靠，具体操作易学等诸多优点，成为最受国人喜爱的系统评价方法。

 

根据上图所示（图片来源：Web of Science），国人对Meta分析的推崇可见一斑。中国在Meta分析发表总数量上已超越美国，独占鳌头，总数高达30000+篇。
当Meta分析几乎已经覆盖了所有可研究的医学领域后，竞争将会变得更加激烈。普通的Meta分析渐渐得不再能满足各杂志编辑的要求，发文的压力在逼迫研究者们不断创新，僧多粥少的现象愈发明显。meta分析不好发了！

近年来，《Lancet》、《JAMA》等顶刊发表网状meta分析的文章还是能看到。作为一种在传统meta分析基础上发展起来的系统评价的新类型被广泛运用于临床决策。

 

在所有人都聚焦于普通的Meta时，何不转移方向，去尝试一番相对复杂些许的网状Meta分析？

 

《2日网状META分析集训营第一期》
开始免费招生了
报名方式：添加班主任，回复【集训营】
截止10月9日，仅限前1000名

请截屏微信扫码

 

收获满满

 

让你通过本期直播，熟练掌握：

你通本期直播，熟练掌握：

√入门网状Meta并学习分析原理

√了解网状meta的分析步骤与流程

√掌握网状meta的各种常见结果与解读方法

 

更更多福利：多福利：

√高额奖学金：连续两天学习打卡即可参与瓜分

√抽奖：完成课后习题即可参与抽奖（华为蓝牙音箱，全自动多功能雨伞，定制多功能皮质笔记本）

 

 

金牌讲师

理解更透彻 教学质量保障

 

周老师是重庆医科大学第四临床学院的讲师，曾发表过多篇网状meta分析SCI，最高分7.7分，非常熟悉网状meta分析的理论及Stata、R软件等多个软件的实战操作，也帮助过数百人成功发表SCI。

 

本期训练营须知

手把手教学  走进网状META分析

 

只要你是：

希望学习网状meta分析原理及应用方法的科研人员

想初步上手网状meta分析的临床研究人员

零基础的研究生

迫切希望发表SCI文章晋升的临床工作者

 

本次速成班特别适合初学者和无基础的学员。也适合有初步了解的老师进阶！

 

本期集训营学习计划：

 

10月9日：开营仪式

先导课：

第1节 网状meta分析概述

第2节 NMA的三大条件假设

第3节 网状meta分析的方法、步骤及课程大纲简介

课后习题

10月10日：休息日

10月11日：Day1

第1节 建立一个团队

第2节定义一个明确的研究问题

第3节 定义人群和干预措施

第4节 选择结局指标

第5节 所纳入研究类型

第6节 注册

课后习题

10月12日：Day2

第1节 网状图

第2节 联赛图

第3节 一致性

第4节 异质性

第5节 干预的排序

课后习题

10月13日：结营仪式与福利发放

 

看看学员真实学习氛围，完美帮你“避坑”

 

 

视频跟学+每日打卡+课后习题

学习效果up！up！up！

 

加入集训营

 

请截屏微信扫码

识别下方二维码添加班主任

回复【集训营】

报名参加2天网状META集训营

截止10月9日12点，仅限前1000名

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1896898, encodeId=e60518968980e, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Mon May 16 06:21:24 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1888345, encodeId=1808188834585, content=<a href='/topic/show?id=d56611584ec' target=_blank style='color:#2F92EE;'>#Meta#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11584, encryptionId=d56611584ec, topicName=Meta)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Sat Nov 13 09:21:24 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078462, encodeId=6b3e10e846206, content=学到了, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f72a5537728, createdName=ms2000000997930621, createdTime=Thu Dec 09 16:13:46 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055164, encodeId=13d5105516487, content=学到了, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210818/fc28215f52d5420bbf7edf4303dd3a05/a27dc401923347c494bf44b40c018416.jpg, createdBy=8cf55468929, createdName=kukuya, createdTime=Sun Sep 26 22:00:11 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054980, encodeId=dddd1054980cc, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4faf5617473, createdName=ms5000000478457611, createdTime=Sun Sep 26 14:31:50 CST 2021, time=2021-09-26, status=1, ipAttribution=)]
    2022-05-16 一闲

    #MET#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1896898, encodeId=e60518968980e, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Mon May 16 06:21:24 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1888345, encodeId=1808188834585, content=<a href='/topic/show?id=d56611584ec' target=_blank style='color:#2F92EE;'>#Meta#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11584, encryptionId=d56611584ec, topicName=Meta)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Sat Nov 13 09:21:24 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078462, encodeId=6b3e10e846206, content=学到了, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f72a5537728, createdName=ms2000000997930621, createdTime=Thu Dec 09 16:13:46 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055164, encodeId=13d5105516487, content=学到了, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210818/fc28215f52d5420bbf7edf4303dd3a05/a27dc401923347c494bf44b40c018416.jpg, createdBy=8cf55468929, createdName=kukuya, createdTime=Sun Sep 26 22:00:11 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054980, encodeId=dddd1054980cc, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4faf5617473, createdName=ms5000000478457611, createdTime=Sun Sep 26 14:31:50 CST 2021, time=2021-09-26, status=1, ipAttribution=)]
    2021-11-13 guojianrong

    #Meta#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1896898, encodeId=e60518968980e, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Mon May 16 06:21:24 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1888345, encodeId=1808188834585, content=<a href='/topic/show?id=d56611584ec' target=_blank style='color:#2F92EE;'>#Meta#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11584, encryptionId=d56611584ec, topicName=Meta)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Sat Nov 13 09:21:24 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078462, encodeId=6b3e10e846206, content=学到了, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f72a5537728, createdName=ms2000000997930621, createdTime=Thu Dec 09 16:13:46 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055164, encodeId=13d5105516487, content=学到了, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210818/fc28215f52d5420bbf7edf4303dd3a05/a27dc401923347c494bf44b40c018416.jpg, createdBy=8cf55468929, createdName=kukuya, createdTime=Sun Sep 26 22:00:11 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054980, encodeId=dddd1054980cc, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4faf5617473, createdName=ms5000000478457611, createdTime=Sun Sep 26 14:31:50 CST 2021, time=2021-09-26, status=1, ipAttribution=)]
    2021-12-09 ms2000000997930621

    学到了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1896898, encodeId=e60518968980e, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Mon May 16 06:21:24 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1888345, encodeId=1808188834585, content=<a href='/topic/show?id=d56611584ec' target=_blank style='color:#2F92EE;'>#Meta#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11584, encryptionId=d56611584ec, topicName=Meta)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Sat Nov 13 09:21:24 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078462, encodeId=6b3e10e846206, content=学到了, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f72a5537728, createdName=ms2000000997930621, createdTime=Thu Dec 09 16:13:46 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055164, encodeId=13d5105516487, content=学到了, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210818/fc28215f52d5420bbf7edf4303dd3a05/a27dc401923347c494bf44b40c018416.jpg, createdBy=8cf55468929, createdName=kukuya, createdTime=Sun Sep 26 22:00:11 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054980, encodeId=dddd1054980cc, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4faf5617473, createdName=ms5000000478457611, createdTime=Sun Sep 26 14:31:50 CST 2021, time=2021-09-26, status=1, ipAttribution=)]
    2021-09-26 kukuya

    学到了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1896898, encodeId=e60518968980e, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Mon May 16 06:21:24 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1888345, encodeId=1808188834585, content=<a href='/topic/show?id=d56611584ec' target=_blank style='color:#2F92EE;'>#Meta#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11584, encryptionId=d56611584ec, topicName=Meta)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Sat Nov 13 09:21:24 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078462, encodeId=6b3e10e846206, content=学到了, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f72a5537728, createdName=ms2000000997930621, createdTime=Thu Dec 09 16:13:46 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055164, encodeId=13d5105516487, content=学到了, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210818/fc28215f52d5420bbf7edf4303dd3a05/a27dc401923347c494bf44b40c018416.jpg, createdBy=8cf55468929, createdName=kukuya, createdTime=Sun Sep 26 22:00:11 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054980, encodeId=dddd1054980cc, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4faf5617473, createdName=ms5000000478457611, createdTime=Sun Sep 26 14:31:50 CST 2021, time=2021-09-26, status=1, ipAttribution=)]
    2021-09-26 ms5000000478457611

    学习了

    0

相关资讯

Cancers：放疗联合S-1治疗头颈部肿瘤的的疗效和安全性：来自Meta分析

该meta分析表明S-1联合放疗治疗头颈部肿瘤表现出现良好的肿瘤缓解和生存，尤其在喉癌中，并且毒性可耐受。因此，有必要开展大型的随机对照研究（RCT）来证实两者联合治疗的疗效和安全性。

临床医生如何解读Meta分析论文？

Meta分析是翻译自英文meta-analysis，其中“Meta”一词源于古希腊文，意指将事物综合起来观察。

Translational Psychiatry：杏仁核功能障碍可能与边缘性人格障碍发病机制有关

杏仁核功能障碍可能代表了边缘性人格障碍一种很有前途的病理生理机制，是一种新的治疗策略的良好靶点，然而，相反，它也可能是情绪处理和调节困难的辅助诊断标志物。

网状meta分析案例，以及网络meta图表制作方法及软件

Meta分析已经成为现在临床决策中非常关键的一部分，而网状Meta分析作为Meta分析的拓展，也在近些年被大力发展并应用于临床决策。为了区分，我们通常称传统Meta分析为pairwise Meta分析

临床预测模型的网状Meta分析

临床预测模型或预后评分近年来应用越来越广泛，它们通过对个体某些特征指标如实验室检验或症状、体征等的利用来估计现在或未来发生某特定事件的风险，为医疗决策提供一定的科学依据。目前，在很多疾病领域针对同一个

今晚19:00直播：潘岳松副研究员：如何评价系统综述与Meta分析

👉 扫描海报二维码0元报名，还能抽领《系统评价、Meta-分析设计与实施方法》纸质书1本

Baidu
map
Baidu
map
Baidu
map